Showing 26 of 26 results

Guinea-Bissau Government
Guinea-Bissau_Rapport Final RIA,Guinea-Bissau_Rapport Final RIA
Guinea-Bissau Government
Guinea-Bissau_Vaccination Intra-Action review (IAR) report,Guinea-Bissau_Vaccination Intra-Action review (IAR) report
Banque Mondiale, Organisation Mondiale de la Santé (OMS)
Guinée Bissau: Analyse de la réponse du pays à la COVID-19 et identification des meilleures pratiques et des lacunes cruciales à prendre en compte dans les futurs plans d’intervention pratiques...
World Bank, World Health Organization (WHO)
Guinea Bissau: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans,Guinea Bissau: Analysis of country COVID-19 response,...
Home-based record (HBR) for Guinea-Bissau circa 2008
Home-based record (HBR) for Guinea-Bissau circa 2008 (maternal)
Home-based record (HBR) for Guinea-Bissau circa 2010 (TT)
Home-based record (HBR) for Guinea-Bissau circa 2005
World Health Organization (WHO)
From 24-30 April 2016, countries in the African Region commemorated the 6th African Vaccination Week (AVW).The goal of AVW is to strengthen immunization programmes in the African...
S. Byberg et al.
Background Measles vaccination campaigns targeting children aged 9–59 months are conducted every three years in Guinea-Bissau. Studies have demonstrated beneficial non-specific effects of...
Mable Carole Tevi-Benissan et al.
Background Significant progress has been made to increase access to vaccines in Africa since the 1974 launch of the Expanded Programme on Immunization (EPI). Successes include the introduction of...
Frank Shann
There is now clear evidence that the simplistic conventional model of immunization is invalid [1]. We can no longer assume that a vaccine acts independently of other vaccines, or that it influences...
Catherine Bruckner & Francesco Checchi
Fragile states are home to a sixth of the world\'s population, and their populations are particularly vulnerable to infectious disease outbreaks. Timely surveillance and control are essential to...
Kristoffer Jarlov Jensen et al.
Vaccines may have non-specific effects. An observational study from Guinea-Bissau suggested that oral polio vaccine at birth (OPV0) provided with Bacillus Calmette–Guérin (BCG) vaccine was...
Ane B. Fisker, Linda Hornshøj, Amabelia Rodrigues, Ibraima Balde, Manuel Fernandes, Christine S. Benn, Peter Aaby
In 2008, the GAVI Alliance funded the introduction of new vaccines (including pentavalent diphtheria-tetanus-pertussis [DTP] plus hepatitis B and Haemophilus influenzae type b antigens) in...
World Health Organization (WHO)
This report highlights the achievements made in expanding access to vaccines in Africa and discusses some of the remaining challenges to achieving universal access to vaccines. The timing of this...
Studies from low-income countries indicate that co-administration of inactivated diphtheria–tetanus–pertussis (DTP) vaccine and live attenuated measles vaccine (MV) is associated with increased...
Ane B. Fisker, Carlito Bale, Amabelia Rodrigues, Ibraima Balde, Manuel Fernandes, Mathias J. Jørgensen, Niels Danneskiold-Samsøe, Linda Hornshøj, Julie Rasmussen, Emil D. Christensen, Bo M. Bibby, Peter Aaby, Christine S. Benn
The World Health Organization recommends vitamin A supplementation (VAS) at routine vaccination contacts after 6 months of age based on the assumption that it reduces mortality by 24%. The policy has...
Thysen SM et al.
BCG vaccination is recommended at birth in low-income countries, but vaccination is often delayed. Often 20-dose vials of BCG are not opened unless at least ten children are present for vaccination...
Katie L. Flanagan, Guest Editor
The WHO Strategic Advisory Group of Experts (SAGE) on immunization recently published their conclusions from a systematic review of the ‘non-specific’ or ‘heterologous effects’ of vaccines,...
Erliyani Sartono et al.
This study is the first to address the consequences for the immune response to BCG of simultaneous administration with OPV. Worryingly, the results indicate that the common practice in low-income...
Kathleen Tiffay et al.
The development, through a public–private partnership, of a safe, effective, and affordable vaccine for sub-Saharan Africa, PsA-TT, offers a new paradigm for the development of vaccines...
M. Teresa Aguado et al.
In June 2001, BMGF awarded a grant of US$70 million to create the Meningitis Vaccine Project (MVP) as a partnership between PATH and WHO, with the specific goal of developing an affordable MenA...
Najaaraq Lund et al.
The researchers investigated the effect of OPV0 on infant mortality in a randomized trial in Guinea-Bissau. The study concludes that OPV0 may be associated with nonspecific protection against...
Amabelia Rodrigues, Ane B. Fisker, Cesario Martins, Henrik Ravn, Stine Byberg, Sanne Thysen, Line Storgaard, Marie Pedersen, Manuel Fernandes, Christine S. Benn, Peter Aaby
Randomised trials have shown that measles vaccine (MV) prevents non-measles deaths. MV-campaigns are conducted to eliminate measles infection.The overall mortality effect of MV-campaigns has not been...
International Vaccine Access Center (IVAC)
The following report displays data and figures on the introduction status of Hib vaccine, pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV)* both globally...